Objective To establish an animal model that stably mimics the pathological features of pulmonary emphysema combined with pulmonary bullous disease, providing an experimental tool for studying the mechanisms of bullous volume reduction surgery and pneumothorax complications. Methods New Zealand white rabbits were subjected to cigarette smoke exposure combined with tracheal instillation/nebulized trypsin to induce emphysema with pulmonary bullae, mimicking human pathophysiological changes. The rabbits were exposed to cigarette smoke for 37 days, 40 cigarettes per day, for 1 hour (tar content 11 mg, carbon monoxide in smoke 12 mg, nicotine in smoke 1.1 mg). On the 2nd day of modeling, trypsin [10 000 U/rabbit, dissolved in 1 mL sterile phosphate-buffered saline (PBS) ] was instilled into the trachea. On the 15th and 36th days, trypsin (10 000 U/rabbit, dissolved in 1 mL sterile PBS) was nebulized for inhalation. Computed Tomography (CT) imaging, macroscopic examination, and histopathological analysis assessed emphysema severity, bulla formation, and inflammatory cell infiltration in model animals. Results Imaging, gross appearance, and histopathological findings demonstrated that the model group rabbits successfully developed pulmonary emphysema with pulmonary bullous disease: CT revealed extensive diffuse areas of low density and thin-walled cystic lucent shadows; lung tissue exhibited increased volume, reduced elasticity, and visible vesicular protrusions on the surface; hematoxylin-eosin staining (HE) confirmed ruptured and fused alveolar septa forming large cavities, diffuse alveolar enlargement, and chronic inflammatory cell infiltration. Model group animals exhibited corresponding behavioral changes such as tachypnea and reduced activity, while no such abnormalities were observed in the control group. Conclusion In this study, we successfully established a model of emphysema with bullae in New Zealand white rabbits using a dual administration method. The method combined cigarette smoke exposure with tracheal instillation and nebulized trypsin inhalation. The approach integrates the benefits of both administration routes, which reduces operational difficulty and animal mortality, while enhancing the success rate of model establishment.
Key words
pulmonary emphysema /
pulmonary bullae /
animal model /
cigarette smoke /
trypsin
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] RHEE CK, CHAU NQ, YUNUS F, et al.Management of COPD in Asia: a position statement of the Asian Pacific Society of Respirology[J]. Respirol, 2019, 24(10): 1018-1025.
[2] JANSSEN R, PISCAER I, FRANSSEN FME, et al.Emphysema: looking beyond alpha-1 antitrypsin deficiency[J]. Expert Rev Respir Med, 2019, 13(4): 381-397.
[3] TERADA Y, YUKI H, NISHIKAWA S, et al.Lung volume reduction in chronic obstructive pulmonary disease[J]. Kyobu Geka, 2025, 78(7): 515-521.
[4] SAMANTA RP, AGARWAL S, SENGUPTA S.Giant bullous emphysema mimicking spontaneous pneumothorax[J]. Cureus, 2022, 14(11): e31182.
[5] MACDUFF A, ARNOLD AG, HARVEY J.Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010[J]. Thorax, 2010, 65(2): 18-31.
[6] RANA JS, KHAN SS, LLOYD-JONES DM, et al.Changes in mortality in top 10 causes of death from 2011 to 2018[J]. J Gen Intern Med, 2021, 36(8): 2517-2518.
[7] ZUO X, LOU P, ZHU Y, et al.Effects of expressive art therapy on health status of patients with chronic obstructive pulmonary disease: a community-based cluster randomized controlled trial[J]. Ther Adv Respir Dis, 2022, 16: 17534666221111876.
[8] YANG Y, DI T, ZHANG Z, et al.Dynamic evolution of emphysema and airway remodeling in two mouse models of COPD[J]. BMC Pulm Med, 2021, 21(1): 134.
[9] ZHANG K, GUO L, WEI Q, et al.COPD rat model is more susceptible to cold stress and PM 2.5 exposure and the underlying mechanism[J]. Environ Pollut, 2018, 241: 26-34.
[10] CHAN CS, LIN YS, LIN YK, et al.Atrial arrhythmogenesis in a rabbit model of chronic obstructive pulmonary disease[J]. Transl Res, 2020, 223: 25-39.
[11] PRITCHETT-CORNING KR, GIROD A, AVELLANEDA G, et al.Handbook of clinical signs in rodents and rabbits[M]. Wilmington: Charles River Laboratories, 2010.
[12] AGUSTĺ A, CELLI BR, CRINER GJ, et al.Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary[J]. Eur Respir J, 2023, 61(4): 2300239.
[13] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南 (2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
[14] 周利润, 崔晓兰. 慢性阻塞性肺疾病相关动物模型研究进展[J]. 中国实验动物学报, 2022, 30(8): 1121-1127.
[15] MANNINO DM, BUIST AS.Global burden of COPD: risk factors, prevalence, and future trends[J]. Lancet, 2007, 370(9589): 765-773.
[16] 何家祺, 周园园, 聂永强, 等. 香烟烟雾暴露诱导慢性阻塞性肺疾病小鼠模型的构建及多维度病理评估[J]. 实验动物与比较医学, 2026, 46(1): 11-19.
[17] BIANCHERA A, VILARDO V, GIACCARI R, et al.Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin[J]. Deliv Transl Res.2023, 13(10): 2653-2663.
[18] BRENNER M, GONZALEZ X, JONES B, et al.Effects of a novel implantable elastomer device for lung volume reduction surgery in a rabbit model of elastase-induced emphysema[J]. Chest, 2002, 121(1): 201-209.
[19] 陈玲. 香烟提取物与转化生长因子-β1对慢阻肺气道平滑肌细胞的影响研究[D]. 重庆: 重庆大学, 2014.
[20] JO YS, RHEE CK, YOON HK, et al.Evaluation of asthmachronic obstructive pulmonary disease overlap using a mouse model of pulmonary disease[J]. J Inflamm, 2022, 19(1): 25.
[21] TANAKA S, DATE N, IMAMURA Y, et al.Pulmonary cyst newly formed after lobectomy in various underlying lung conditions[J]. Surg Case Rep, 2024, 10(1): 56.